Dr Reddy’s, Sun Pharma recall products due to manufacturing issues in United States | The Financial Express

Dr Reddy’s, Sun Pharma recall products due to manufacturing issues in United States

According to industry estimates, the US generic drug market was estimated at around USD 115.2 billion in 2019. It is the largest market for pharmaceutical products.

Dr Reddy’s, Sun Pharma recall products due to manufacturing issues in United States
Dr. Reddy's Laboratories (File)

Dr. Reddy’s Laboratories and Sun Pharma are recalling different products in the United States market for manufacturing issues, according to the US Food and Drug Administration.

As per the enforcement report by the US health regulator, the US-based arm of Dr. Reddy’s Laboratories is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose. It is recalling 25,176 cartons of 30-count tablets and 22,968 cartons of 20-count tablets, according to a report by the news agency PTI.

According to USFDA, Dr Reddy’s Laboratories is recalling the affected lot due to “failed stability specifications”.

Reportedly, Dr Reddy’s Laboratories, Inc initiated the Class III recall on November 21 this year.

As per USFDA, a Class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences”.

The health regulator further said the US-based arm of Sun Pharma is recalling 14,064 cartons of a medication to treat erosive esophagitis or heartburn caused by gastroesophageal reflux disease (GERD). The company is recalling the affected lot, produced at its Mohali plant, due to “discoloration”, it added.

Sun Pharmaceutical Industries Inc commenced the Class II voluntary recall in the US on July 25 this year. As per USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

According to industry estimates, the US generic drug market was estimated at around USD 115.2 billion in 2019. It is the largest market for pharmaceutical products.

(With inputs from PTI)

ALSO READ | Dr. Reddy’s Labs partners with IQVIA for improving customer interaction service in India

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

First published on: 05-12-2022 at 11:22 IST